Cigna Group CI · USD
Health Care · Health Care Providers & Services · US listing · 🇺🇸 United States
S&P 500
295.60
+0.68%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$274.95bn
FY2016FY2025
Net income
$5.96bn
FY2016FY2025
Free cash flow
$8.39bn
FY2016FY2025
Shareholders' equity
$41.71bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $274.95bn | $247.12bn | $195.26bn | $180.52bn | $174.07bn | $160.40bn | $153.57bn | $48.65bn | $41.81bn | $39.84bn |
| Operating income | $9.13bn | $9.42bn | $8.54bn | $8.45bn | $7.94bn | $8.15bn | $8.08bn | $4.16bn | $3.94bn | $3.09bn |
| Net income | $5.96bn | $3.43bn | $5.16bn | $6.70bn | $5.37bn | $8.46bn | $5.10bn | $2.64bn | $2.24bn | $1.87bn |
| Diluted earnings per share | 22.40 | 12.36 | 17.53 | 21.95 | 16.29 | 23.42 | 13.78 | 10.87 | 8.98 | 7.31 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $157.92bn | $155.88bn | $152.76bn | $143.88bn | $154.89bn | $155.45bn | $155.77bn | $153.23bn | $61.76bn | $59.36bn |
| Cash and short-term investments | $7.68bn | $8.21bn | $8.75bn | $6.83bn | $6.00bn | $11.51bn | $5.56bn | $5.90bn | $3.17bn | $3.88bn |
| Total liabilities | $116.05bn | $114.64bn | $106.41bn | $98.98bn | $107.70bn | $105.06bn | $110.39bn | $112.15bn | $47.97bn | $45.58bn |
| Debt | $31.46bn | $31.97bn | $30.93bn | $31.09bn | $33.67bn | $32.92bn | $37.41bn | $42.48bn | $5.44bn | $5.03bn |
| Shareholders' equity | $41.71bn | $41.03bn | $46.22bn | $44.87bn | $47.11bn | $50.32bn | $45.34bn | $41.03bn | $13.73bn | $13.72bn |
| Shares outstanding | 266m | 278m | 295m | 305m | 330m | 361m | 370m | 243m | 249m | 256m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $9.60bn | $10.36bn | $11.81bn | $8.66bn | $7.19bn | $10.35bn | $9.48bn | $3.77bn | $4.09bn | $4.03bn |
| Capital spending | −$1.21bn | −$1.41bn | −$1.57bn | −$1.29bn | −$1.15bn | −$1.09bn | −$1.05bn | −$528.0m | −$471.0m | −$461.0m |
| Free cash flow | $8.39bn | $8.96bn | $10.24bn | $7.36bn | $6.04bn | $9.26bn | $8.44bn | $3.24bn | $3.62bn | $3.56bn |
| Dividends paid | −$1.61bn | −$1.57bn | −$1.45bn | −$1.38bn | −$1.34bn | −$15.0m | −$15.0m | −$24.34bn | −$1.66bn | — |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $71.67bn | $68.49bn | $72.47bn | $69.75bn | $67.23bn | $65.50bn | $65.65bn | $63.69bn |
| Operating income | $2.68bn | $2.36bn | $2.15bn | $2.58bn | $2.43bn | $1.97bn | $2.17bn | $2.58bn |
| Net income | $1.66bn | $1.65bn | $1.23bn | $1.87bn | $1.53bn | $1.32bn | $1.42bn | $739.0m |
| Diluted earnings per share | 6.29 | 6.27 | 4.64 | 7.02 | 5.76 | 4.97 | 5.13 | 2.66 |
| Cash from operations | −$421.0m | $1.13bn | $6.15bn | $3.42bn | −$1.89bn | $1.92bn | $5.21bn | $46.0m |
| Capital spending | −$297.0m | −$267.0m | −$322.0m | −$278.0m | −$285.0m | −$327.0m | −$337.0m | −$399.0m |
| Free cash flow | −$718.0m | $864.0m | $5.83bn | $3.14bn | −$2.17bn | $1.59bn | $4.88bn | −$353.0m |
| Total assets | $157.08bn | $153.27bn | $157.92bn | $157.92bn | $151.65bn | $150.66bn | $155.88bn | $157.64bn |
| Cash and short-term investments | $6.30bn | $7.85bn | $7.68bn | $6.91bn | $5.14bn | $9.06bn | $8.21bn | $6.75bn |
| Debt | $31.88bn | $30.90bn | $31.46bn | $34.04bn | $30.77bn | $30.45bn | $31.97bn | $32.80bn |
| Shareholders' equity | $42.62bn | $42.21bn | $41.71bn | $41.80bn | $40.21bn | $40.23bn | $41.03bn | $42.09bn |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 15.1% | 11.4% | 21.9% |
| Operating income | 2.6% | 2.3% | -3.0% |
| Net income | -3.9% | -6.8% | 11.0% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 3.6% | 4.0% | 4.2% | 5.4% |
| Net margin | 1.8% | 2.4% | 2.8% | 3.2% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 12.3 | 22.3 | 17.1 | 15.1 | 14.1 | 8.9 | 14.8 | 17.5 | 22.6 | 18.3 |
| Price to sales | 0.3 | 0.3 | 0.5 | 0.6 | 0.4 | 0.5 | 0.5 | 0.9 | 1.2 | 0.9 |
Market value over time
31 Oct 2016 to 11 Sept 2026, in USD
$30.90bn$74.11bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | -3% | -4% | -11% | 52% | 10% | -4% | 14% | -13% | 50% | -6% |
Dividends and splits
Per share, in the currency the company pays
Paid for 37 years. Last went ex-dividend on 8 Sept 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 4.68 | 6.04 | 5.60 | 4.92 | 4.48 | 4.00 | 0.04 | 0.04 |
- 3-for-1 split · 5 Jun 2007
- 3-for-1 split · 18 May 1998
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.